Archive for August, 2009

Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript

Emergent BioSolutions Inc., (EBS)
Q2 2009 Earnings Call
August 6, 2009 5:00 pm ET

Executives
Robert G. Burrows – Vice President, Investor Relations
Fuad El-Hibri – Chairman of the Board, Chief Executive Officer
R. Don Elsey – Chief Financial Officer
Daniel J. Abdun-Nabi – President, Chief Operating Officer
W. James Jackson, Ph.D. – Senior Vice President and Chief Scientific Officer

Analysts
Eric Schmidt [...]

Emergent BioSolutions Inc. (EBS) CEO & Chairman, 10% Owner Fuad El-hibri sells 15,000 Shares

CEO & Chairman, 10% Owner of Emergent BioSolutions Inc. (EBS) Fuad El-hibri sells 15,000 shares of EBS on 08/11/2009 at an average price of $16.78 a share.
EMERGENT BIOSULUTIONS INC. is a leading biopharmaceutical company dedicated to one simple mission – to protect life. EBS develops manufactures and commercializes vaccines and therapeutics that assist the body\’s [...]

Peace Prize awarded to Center for Nonviolence’s Kennedy

Scott Kennedy, cofounder and staff member of the Resource Center for Nonviolence, will receive the 2008 El-Hibri Peace Education Prize the first week of October in Washington, DC. The annual prize is given by the El-Hibri family, Nonviolence International, and the International Peace and Conflict Resolution program at American University.
In a letter notifying Kennedy tha [...]

Rene Moawad Foundation (RMF) USA Holds 14th Annual Washington Gala Dinner

Honors Partnership for Lebanon & Mr. Fuad El-Hibri
Features Lebanese Fashion Designer Jean Fares

The Rene Moawad Foundation, USA will hold its 14th Annual Benefit Gala on Saturday, October 20, 2007 at the Ritz Carlton Hotel in Pentagon City , VA. Since its creation in 1993, RMF-USA has succeeded in assembling a large [...]

Emergent BioSolutions moves forward with typhoid vaccine

Emergent BioSolutions is on the path to finding gold with its typhoid vaccine following positive results in a Phase II trial.
The Maryland-based biopharmaceutical company is developing a single-dose oral drinkable typhoid vaccine aimed to take on Crucell’s three to four dose oral formulation and Sanofi’s injectable formulation. The global travellers market was worth $130m (€92m) [...]

Fuad El-Hibri on Wikipedia

Early Life
Fuad El-Hibri (born March 2, 1958) in Hildesheim, Germany[1] spent his childhood equally in Europe and the Middle East before coming to the USA to get an economics degree from Stanford and an MBA from Yale[1]

Education
Mr.El-Hibri earned a Masters Degree in Public and Private Management from Yale University and a Bachelors Degree with [...]